Literature DB >> 7672046

Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration.

R Manfredi1, A Mazzoni, A Nanetti, F Chiodo.   

Abstract

The present report describes a fatal case of imported AIDS-related disseminated histoplasmosis capsulati infection associated with multiple coexisting infections, diagnosed with cultural recovery of Histoplasma capsulatum var. capsulatum with a commercial radiometric Mycobacterium medium. The epidemiological and clinical features of histoplasmosis capsulati and duboisii in Europe are reviewed by examining also 69 documented cases of Histoplasma capsulatum var. capsulatum infection (25 in AIDS patients) and 17 cases of Histoplasma capsulatum var. duboisii infection (3 in HIV-infected patients), described since 1980. This draws special attention to the role played during recent years by the emergence of the HIV pandemic and the progressive intensification of travel and immigration as risk factors for this disease in our continent. AIDS patients, who are prone to multiple concurrent opportunistic infections which may share clinical and laboratory features with each other and with other HIV-associated diseases, represent the most relevant current group at risk for severe disseminated histoplasmosis, which may come to medical attention far from their place of origin.

Entities:  

Mesh:

Year:  1994        PMID: 7672046     DOI: 10.1007/bf01719280

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  64 in total

1.  Bone-marrow diagnosis of opportunistic infections in HIV disease.

Authors:  C Costello; S Rule; D Shanson; N Mir
Journal:  AIDS       Date:  1992-12       Impact factor: 4.177

2.  [Case n. 4--1991. Thromboembolism accidents, histoplasmosis and pelvic arteriovenous fistula].

Authors:  P Valère; D Thomas; A Delcourt
Journal:  Ann Med Interne (Paris)       Date:  1991

Review 3.  Histoplasmosis and AIDS.

Authors:  J R Graybill
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

4.  Bilateral adrenal masses.

Authors:  W R Gibb; A D Ramsay; N I McNeil; O M Wrong
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-20

5.  [African histoplasmosis; immunological parameters and treatment with ketoconazole].

Authors:  U Kaben; H J Westphal; C Schütt; P Skierlo
Journal:  Mykosen       Date:  1982-10

6.  Disseminated histoplasmosis.

Authors:  A W Johnston; R Postlethwaite; S W Ewen; R J Hay
Journal:  J Infect       Date:  1984-07       Impact factor: 6.072

7.  [African histoplasmosis of the lung (author's transl)].

Authors:  H P Seeliger; J Kracht; A Bikfalvi
Journal:  Dtsch Med Wochenschr       Date:  1980-04-25       Impact factor: 0.628

Review 8.  Disseminated histoplasmosis in patients infected with human immunodeficiency virus.

Authors:  G A Sarosi; P C Johnson
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

9.  Histoplasmosis in patients with acquired immunodeficiency syndrome. Hematologic and bone marrow manifestations.

Authors:  P J Kurtin; D S McKinsey; M R Gupta; M Driks
Journal:  Am J Clin Pathol       Date:  1990-03       Impact factor: 2.493

10.  Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?

Authors:  F J Medrano; J Hernández-Quero; E Jiménez; J A Pineda; A Rivero; A Sánchez-Quijano; I D Velez; P Viciana; R Castillo; M J Reyes
Journal:  AIDS       Date:  1992-12       Impact factor: 4.177

View more
  15 in total

1.  Spinal African histoplasmosis simulating tuberculous spondylitis.

Authors:  F Musoke
Journal:  Afr Health Sci       Date:  2001-08       Impact factor: 0.927

2.  Hyphal and yeast forms of Histoplasma capsulatum growing within 5 days in an automated bacterial blood culture system.

Authors:  Hossein Salimnia; Patricia Brown; Paul Lephart; Marilynn R Fairfax
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

3.  Disseminated histoplasmosis in an HIV-infected patient discovered by routine blood smear staining.

Authors:  R Matulionyte; J Garbino; I Uçkay; J F Lambert; B Hirschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

4.  Cutaneous manifestations of endemic mycoses.

Authors:  Jeannina A Smith; James Riddell; Carol A Kauffman
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

5.  Disseminated histoplasmosis in a domestic cat imported from the USA to Austria.

Authors:  Andrea Klang; Igor Loncaric; Joachim Spergser; Sabine Eigelsreiter; Herbert Weissenböck
Journal:  Med Mycol Case Rep       Date:  2013-04-23

6.  Imported African histoplasmosis in an immunocompetent patient 40 years after staying in a disease-endemic area.

Authors:  Clémence Richaud; Marie-Olivia Chandesris; Fanny Lanternier; Hélène Benzaquen-Forner; Dea Garcia-Hermoso; Capucine Picard; Emilie Catherinot; Marie-Elisabeth Bougnoux; Olivier Lortholary
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

7.  Histoplasmosis infection in Spanish travelers to Latin America.

Authors:  J Gascón; J M Torres; M Jiménez; T Mejias; L Triviño; F Gobbi; L Quintó; J Puig; M Corachan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

8.  Phylogenetic relationships of varieties and geographical groups of the human pathogenic fungus Histoplasma capsulatum Darling.

Authors:  T Kasuga; J W Taylor; T J White
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area.

Authors:  F Poveda; J García-Alegría; M A de las Nieves; E Villar; N Montiel; A del Arco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

Review 10.  Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review.

Authors:  R Martin-Iguacel; J Kurtzhals; G Jouvion; S D Nielsen; J M Llibre
Journal:  Infection       Date:  2014-03-14       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.